Skip to main content

Table 1 The main characteristics of patients at baseline

From: Behavioral activation versus treatment as usual in naturalistic sample of psychiatric patients with depressive symptoms: a benchmark controlled trial

 

Intervention group

Control group

 

n (%)

n (%)

pe

Number of patients

242

205

 

Female / Male

148 (61.2) / 94 (38.8)

111 (54.1) / 94 (45.9)

0.135

Outpatient / Inpatient

189 (78.1) / 53 (21.9)

156 (76.1) / 49 (23.9)

0.615

Register basedf clinical diagnosis (ICD-10):

Primary psychiatric diagnosis

  

0.103

 Depressive disorder (F32.x)

98 (40.5)

89 (50.0)

 

 Recurrent depressive disorder (F33.x)

92 (38.0)

48 (27.0)

 

 Bipolar disorder (F31.x)

19 (7.9)

17 (9.6)

 

 Anxiety disorders (F40–43.x)

9 (3.7)

20 (9.6)

 

 Other disorders

18 (7.4)

 

Secondary psychiatric diagnosis

 Panic disorder (F41.x)

26 (10.7)

16 (7.8)

0.296

 Phobic and other anxiety disorders (F40,42,43.x)

22 (9.1)

22 (10.8)

0.550

 Personality disorder (F6x.x)

9 (3.7)

17 (8.4)

0.037

Tertiary psychiatric diagnosis

 Anxiety disorder (F4x.x)

12 (5.0)

5 (2.5)

0.168

 Personality disorder (F6x.x)

8 (3.3)

10 (4.9)

0.393

Alcohol dependence (current)

47 (19.4)

n/a

 

Use of other substance (last 12 months)

22 (9.1)

n/a

 
 

mean (SD)

mean (SD)

p

Age (years)

38.8 (12.2)

39.5 (12.7)

0.567

Baseline MADRSa

23.2 (6.7)

n/a

 

Baseline BDIb

27.9 (7.3)

28.8 (7.9)

0.214

Baseline AUDITc

10.7 (9.9)

9.8 (9.0)

0.319

Baseline GAFd

45.9 (10.7)

43.6 (11.7)

0.035

  1. aMontgomery–Åsberg Depression Rating Scale
  2. bBeck Depression Inventory
  3. cAlcohol Use Disorders Identification Test
  4. dGlobal Assessment of Functioning scale
  5. ebetween groups (chi-square test)
  6. fRegister based diagnoses determined by the responsible doctor in previous treatment contacts